Blog

In recent years, artificial intelligence (AI) has rapidly become a cornerstone of innovation in life sciences. But while headlines often focus on its use in radiology or drug discovery, a quieter revolution is taking place in microbiology — one that may prove just as transformative, particularly for preclinical research in infectious diseases.

In the face of escalating antimicrobial resistance (AMR), researchers and innovators are turning to advanced technologies like Artificial Intelligence (AI) and genomic sequencing to pave new roads in the battle against superbugs.